Antiviral Effect of Emodin from Rheum palmatum against Coxsakievirus B5 and Human Respiratory Syncytial Virus In Vitro

被引:0
|
作者
刘钊 [1 ,2 ]
马年 [2 ]
钟研 [2 ]
杨占秋 [2 ]
机构
[1] South-Central University for Nationalities
[2] State Key Laboratory of Virology, Institute of Medical Virology, School of Medicine, Wuhan University
基金
中国国家自然科学基金;
关键词
emodin; antiviral effect; coxsakievirus B 5; respiratory syncytial virus;
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
1008 ;
摘要
Viral infections are the major causes of morbidity and mortality in elderly people and young children throughout the world. The most common pathogens include coxsackie virus(CV) and respiratory syncytial virus(RSV). However, no antiviral agents with low toxicity and drug resistance are currently available in clinic therapy. The present study aimed to examine the antiviral activities of emodin(an ingredient of Rheum palmatum) against CVB5 and RSV infections, in an attempt to discover new antiviral agents for virus infection. The monomer emodin was extracted and isolated from Rheum palmatum. The antiviral activities of emodin on HEp-2 cells were evaluated, including virus replication inhibition, virucidal and anti-absorption effects, by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide(MTT) assay and plaque reduction assay(PRA). The kinetics of virus inhibition by emodin in a period of 14 h was further determined by plaque assay and quantitative real time PCR(q PCR). Cytokine(IFN-γ, TNF-α) m RNA expressions after emodin treatment(7.5, 15, 30 μmol/L) were also assessed by q PCR post-infection. The results showed that emodin had potent inhibitory activities against CVB5 and RSV, with the 50% effective concentration(EC50) ranging from 13.06 to 14.27 μmol/L and selectivity index(SI) being 5.38–6.41 μmol/L. However, emodin couldn’t directly inactivate the viruses or block their absorption to cells. It acted as a biological synthesis inhibitor against CVB4 and RSV in a concentration- and time-dependent manner, especially during the first 0–4 h post-infection. Moreover, emodin could decrease the m RNA expression of IFN-α but enhance TNF-γ expression significantly compared to the viral controls in vitro. Our results provide a molecular basis for development of emodin as a novel and safe antiviral agent for human enterovirus and respiratory virus infection in the clinical therapy.
引用
收藏
页码:916 / 922
页数:7
相关论文
共 50 条
  • [21] Antiviral activity of polysaccharide extract from Laminaria japonica against respiratory syncytial virus
    Cao, Yin-guang
    Hao, Yu
    Li, Zhi-hui
    Liu, Shun-tao
    Wang, Le-xin
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1705 - 1710
  • [22] In vitro antiviral effect of sulfated pectin from Mangifera indica against the infection of the viral agent of childhood bronchiolitis (Respiratory Syncytial Virus - RSV)
    Barboza, Mario Gabriel Lopes
    Dyna, Andre Luiz
    Lima, Thiago Ferreira
    Tavares, Eliandro Reis
    Yamada-Ogatta, Sueli Fumie
    Deduch, Flavia
    Orsato, Alexandre
    Toledo, Karina Alves
    Cunha, Arcelina Pacheco
    Ricardo, Nagila Maria Pontes Silva
    Galhardi, Ligia Carla Faccin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 280
  • [23] Interferon Epsilon-Mediated Antiviral Activity Against Human Metapneumovirus and Respiratory Syncytial Virus
    Martinez-Espinoza, Ivan
    Babawale, Pius I.
    Miletello, Hannah
    Cheemarla, Nagarjuna R.
    Guerrero-Plata, Antonieta
    VACCINES, 2024, 12 (10)
  • [24] Antiviral and Anti-inflammatory Activity of berberine Against Respiratory Syncytial Virus Infection: an In Vitro Study
    Cui, Yujuan
    Zhang, Liangjun
    Hu, Dandong
    Yang, Yingli
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (10): : 2046 - 2052
  • [25] The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
    Currie, Silke M.
    Findlay, Emily Gwyer
    McHugh, Brian J.
    Mackellar, Annie
    Man, Tian
    Macmillan, Derek
    Wang, Hongwei
    Fitch, Paul M.
    Schwarze, Juergen
    Davidson, Donald J.
    PLOS ONE, 2013, 8 (08):
  • [26] Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection
    Yang, Xiao Xi
    Li, Chun Mei
    Li, Yuan Fang
    Wang, Jian
    Huang, Cheng Zhi
    NANOSCALE, 2017, 9 (41) : 16086 - 16092
  • [27] Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro
    Kullaya, Vesla I.
    de Mast, Quirijn
    van der Ven, Andre
    elMoussaoui, Hicham
    Kibiki, Gibson
    Simonetti, Elles
    de Jonge, Marien I.
    Ferwerda, Gerben
    VIRAL IMMUNOLOGY, 2017, 30 (08) : 576 - 581
  • [28] Prophylactic Effect of Human Lactoferrin Against the Respiratory Syncytial Virus in the Mouse Model
    Gladwell, W.
    Gerrish, K.
    Kleeberger, S. R.
    Menendez, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] The in vitro and in vivo antiviral effects of IGF1R inhibitors against respiratory syncytial virus infection
    Ruan, Pinglang
    Dai, Pei
    Mao, Yu
    Tang, Zhongxiang
    He, Hanlin
    Wu, Guojun
    Qin, Ling
    Tan, Yurong
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [30] Antiviral effects of modified Dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model
    Li, Lan
    Yu, Chen-Huan
    Ying, Hua-Zhong
    Yu, Jing-Mao
    JOURNAL OF ETHNOPHARMACOLOGY, 2013, 147 (01) : 238 - 244